589-15687-31370
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 921 / CA
- Registered
- 2021-02-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-23
Registered in v-safe
-
2021-02-23
Dose 1 — Pfizer-BioNTech
- 2021-02-23
-
2021-02-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-09
-
2021-03-18
Dose 2 — Pfizer-BioNTech
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-20
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Good · Site: PainFree text: Some mild pain in lymph nodes under arm of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
- 2021-03-23
- 2021-04-03
- 2021-04-08
- 2021-04-15
- 2021-05-01
- 2021-06-17
- 2021-09-16
-
2021-12-17
Dose 3 — Pfizer-BioNTech
-
2021-12-21
Survey response — days 1–6 daily, dose 3MedDRA: Heart rate increased — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Accelerated heart rateMedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Survey response — day 7, dose 3MedDRA: Heart rate increased, Palpitations — Feeling: Good · Site: PainFree text: Elevated heart rate and palpitationsMedDRA releases: 2024-11 · check-in free text available
- 2021-12-31
- 2022-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Some mild pain in lymph nodes under arm of injection
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Accelerated heart rate
Release 10 — day 7, dose 3
Systemic reaction (other): Elevated heart rate and palpitations
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release